Association of effective dose to immune cells and vertebral marrow dose with hematologic toxicity during neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma

Abstract Background To explore the correlation between effective dose to immune cells (EDIC) and vertebral bone marrow dose and hematologic toxicity (HT) for esophageal squamous cell carcinoma (ESCC) during neoadjuvant chemoradiotherapy (nCRT). Methods The study included 106 ESCC patients treated wi...

Full description

Bibliographic Details
Published in:BMC Cancer
Main Authors: Meng Zhang, Zhenjiang Li, Yong Yin
Format: Article
Language:English
Published: BMC 2024-06-01
Subjects:
Esophageal squamous cell carcinoma
Neoadjuvant chemoradiotherapy
Hematologic toxicity
Dosimetry parameters
Online Access:https://doi.org/10.1186/s12885-024-12531-z

Internet

https://doi.org/10.1186/s12885-024-12531-z

Similar Items